FI940866A - pH-herkällä laukaisimella varustetut, osmoottiset, hajoavat laitteet aineen vapauttamiseksi - Google Patents
pH-herkällä laukaisimella varustetut, osmoottiset, hajoavat laitteet aineen vapauttamiseksi Download PDFInfo
- Publication number
- FI940866A FI940866A FI940866A FI940866A FI940866A FI 940866 A FI940866 A FI 940866A FI 940866 A FI940866 A FI 940866A FI 940866 A FI940866 A FI 940866A FI 940866 A FI940866 A FI 940866A
- Authority
- FI
- Finland
- Prior art keywords
- beneficial agent
- osmotic
- osmagent
- semipermeable membrane
- release substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/023,227 US5358502A (en) | 1993-02-25 | 1993-02-25 | PH-triggered osmotic bursting delivery devices |
US2322793 | 1993-02-25 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI940866A0 FI940866A0 (fi) | 1994-02-24 |
FI940866A true FI940866A (fi) | 1994-08-26 |
FI113941B FI113941B (fi) | 2004-07-15 |
Family
ID=21813831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI940866A FI113941B (fi) | 1993-02-25 | 1994-02-24 | Menetelmä pH-herkällä laukaisimella varustettujen, osmoottisten, hajoavien välineiden valmistamiseksi aineen vapauttamiseksi |
Country Status (19)
Country | Link |
---|---|
US (2) | US5358502A (fi) |
EP (1) | EP0612520B1 (fi) |
JP (1) | JP2862222B2 (fi) |
CN (1) | CN1098286A (fi) |
AT (1) | ATE202927T1 (fi) |
AU (1) | AU660386B2 (fi) |
CA (1) | CA2116288C (fi) |
DE (1) | DE69427664T2 (fi) |
DK (1) | DK0612520T3 (fi) |
ES (1) | ES2157953T3 (fi) |
FI (1) | FI113941B (fi) |
GR (1) | GR3036497T3 (fi) |
IL (1) | IL108691A0 (fi) |
MX (1) | MX9401396A (fi) |
NO (1) | NO312123B1 (fi) |
NZ (1) | NZ250967A (fi) |
PT (1) | PT612520E (fi) |
TW (1) | TW283641B (fi) |
ZA (1) | ZA941262B (fi) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2723536A1 (fr) * | 1994-08-11 | 1996-02-16 | Seth Pawan | Composition permettant une liberation selective d'un principe actif |
US5800422A (en) * | 1995-06-02 | 1998-09-01 | Alza Corporation | Osmotic device with delayed activation of drug delivery and complete drug release |
US5902605A (en) * | 1996-04-18 | 1999-05-11 | Alza Corporation | Drug delivery device with minimal residual drug retention |
BRPI9802144B1 (pt) * | 1997-05-30 | 2017-03-28 | Ezequiel Mayorga Jorge | dispositivo osmótico multicapa aperfeiçoado |
US6149636A (en) | 1998-06-29 | 2000-11-21 | The Procter & Gamble Company | Disposable article having proactive sensors |
US6186991B1 (en) | 1998-06-29 | 2001-02-13 | The Procter & Gamble Company | Disposable article having a responsive system including a mechanical actuator |
US7772455B1 (en) | 1997-11-14 | 2010-08-10 | The Procter & Gamble Company | Disposable article providing improved management of bodily exudates |
US5916595A (en) * | 1997-12-12 | 1999-06-29 | Andrx Pharmaceutials, Inc. | HMG co-reductase inhibitor |
JP2002500201A (ja) | 1998-01-05 | 2002-01-08 | ユニバーシティ オブ ワシントン | 膜破壊剤を使用する増強された輸送 |
US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
JP2002519108A (ja) | 1998-06-29 | 2002-07-02 | ザ、プロクター、エンド、ギャンブル、カンパニー | 反応システムを有する使い捨て処理製品 |
BR9911748A (pt) | 1998-06-29 | 2001-04-03 | Procter & Gamble | Artigo absorvente, inserto para ser colocado em uma peça de vestuário do usuário, artigo descartável e processo para aumentar a capacidade de remoção de excreções corpóreas da pele de um usuário |
ATE322862T1 (de) | 1998-06-29 | 2006-04-15 | Procter & Gamble | Wegwerfartikel mit frühwarn-messvorrichtung |
US6160198A (en) * | 1998-06-29 | 2000-12-12 | The Procter & Gamble Company | Disposable article having a discontinuous responsive system |
US6342037B1 (en) | 1998-06-29 | 2002-01-29 | The Procter & Gamble Company | Device having fecal component sensor |
US6359190B1 (en) | 1998-06-29 | 2002-03-19 | The Procter & Gamble Company | Device for measuring the volume of a body cavity |
US6372951B1 (en) | 1998-06-29 | 2002-04-16 | The Procter & Gamble Company | Disposable article having sensor to detect impending elimination of bodily waste |
ATE266991T1 (de) | 1998-06-29 | 2004-06-15 | Procter & Gamble | Absorbierender wegwerfartikel mit einem reagierenden system mit einem elektrischen antrieb |
US6433244B1 (en) | 1998-06-29 | 2002-08-13 | The Procter & Gamble Company | Disposable treatment article having a responsive system |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
GB9923045D0 (en) * | 1999-09-29 | 1999-12-01 | Novartis Ag | New oral formulations |
WO2001051092A2 (en) * | 2000-01-07 | 2001-07-19 | University Of Washington | Enhanced transport of agents using membrane disruptive agents |
WO2001070289A2 (en) | 2000-03-20 | 2001-09-27 | Biosphere Medical, Inc. | Injectable and swellable microspheres for tissue bulking |
BR0107147A (pt) * | 2000-08-09 | 2002-06-18 | Panacea Biotec Ltd | Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações |
GB2369997B (en) * | 2000-12-12 | 2004-08-11 | Johnson & Johnson Medical Ltd | Dressings for the treatment of exuding wounds |
DE10100689A1 (de) * | 2001-01-09 | 2002-07-18 | Henkel Kgaa | Wasch- und reinigungsaktive Substanzen enthaltende Mikrokapseln |
US20030104052A1 (en) * | 2001-10-25 | 2003-06-05 | Bret Berner | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
MXPA04005036A (es) * | 2001-11-30 | 2004-08-11 | Bristol Myers Squibb Co | Configuraciones de pipeta y arreglos de las mismas para medir propiedades electricas celulares. |
DE10209979A1 (de) * | 2002-03-07 | 2003-09-25 | Ratiopharm Gmbh | Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung |
US20040062778A1 (en) * | 2002-09-26 | 2004-04-01 | Adi Shefer | Surface dissolution and/or bulk erosion controlled release compositions and devices |
US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
US20040143221A1 (en) * | 2002-12-27 | 2004-07-22 | Shadduck John H. | Biomedical implant for sustained agent release |
TWI355276B (en) * | 2003-01-14 | 2012-01-01 | Akira Tsuji | Gastrointestinal absorption enhancer mediated by p |
US8029822B2 (en) * | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
US20060177507A1 (en) * | 2003-05-22 | 2006-08-10 | Joaquina Faour | Controlled release device containing lercanidipine |
US20050139805A1 (en) * | 2003-11-06 | 2005-06-30 | Dale Koster | Dechlorinating tablet and method of manufacture |
US20040224019A1 (en) * | 2004-03-03 | 2004-11-11 | Adi Shefer | Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs |
WO2005097210A1 (en) * | 2004-03-26 | 2005-10-20 | The University Of Utah Research Foundation | Bioresponsive polymer system for delivery of microbicides |
WO2007098625A1 (en) * | 2006-02-28 | 2007-09-07 | F. Hoffmann-La Roche Ag | Method for assessing absorption properties of low solubility compounds |
US7718193B2 (en) * | 2006-03-16 | 2010-05-18 | University Of Washington | Temperature- and pH-responsive polymer compositions |
CN101534795B (zh) | 2006-11-21 | 2013-04-03 | 麦克内尔-Ppc股份有限公司 | 改进释放的镇痛悬浮液 |
US7981688B2 (en) | 2007-03-08 | 2011-07-19 | University Of Washington | Stimuli-responsive magnetic nanoparticles and related methods |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
DK2170930T3 (da) | 2007-06-04 | 2012-11-05 | Synergy Pharmaceuticals Inc | Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme |
US9833510B2 (en) * | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
US8349387B2 (en) * | 2007-08-29 | 2013-01-08 | Shionogi & Co., Ltd. | Method for production of coated preparations |
JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
EP2344183B1 (en) * | 2008-10-10 | 2015-02-25 | Alvine Pharmaceuticals, Inc. | Dosage forms that facilitate rapid activation of zymogen |
US8426214B2 (en) * | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
WO2011008534A1 (en) * | 2009-06-30 | 2011-01-20 | Boston Scientific Scimed, Inc. | Implantable self-powered biodegradable medical device to treat or prevent reperfusion injury |
WO2011039686A1 (en) | 2009-09-30 | 2011-04-07 | Pfizer Inc. | Latrepirdine oral sustained release dosage forms |
US20110117668A1 (en) * | 2009-11-09 | 2011-05-19 | University Of Washington Through Its Center For Commercialization | Self-powered smart diagnostic devices |
US9080933B2 (en) | 2009-11-09 | 2015-07-14 | University Of Washington Through Its Center For Commercialization | Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates |
WO2011097727A1 (en) | 2010-02-10 | 2011-08-18 | Queen's University At Kingston | Water with switchable ionic strength |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
AU2011342287B2 (en) * | 2010-12-15 | 2015-09-17 | Greencentre Canada | Systems and methods for use of water with switchable ionic strength |
EP2958577A2 (en) | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylate cyclase receptor agonists for use in colonic cleansing |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
JP6041823B2 (ja) | 2013-03-16 | 2016-12-14 | ファイザー・インク | トファシチニブの経口持続放出剤形 |
JP6661531B2 (ja) | 2013-10-10 | 2020-03-11 | シナジー ファーマシューティカルズ インコーポレイテッド | オピオイド誘発性機能障害の治療に有用なグアニル酸シクラーゼのアゴニスト |
US20160060589A1 (en) * | 2014-09-01 | 2016-03-03 | Abnova (Taiwan) Corporation | Particle transporting system and method of operating the same |
EP3365029A2 (en) * | 2015-10-20 | 2018-08-29 | Takasago International Corporation | Fragrance delivery device, system, and method |
JP6944822B2 (ja) * | 2017-06-27 | 2021-10-06 | 持田製薬株式会社 | 易服用性カプセル |
WO2021014360A1 (en) | 2019-07-23 | 2021-01-28 | Pfizer Inc. | Oral modified release dosage forms |
US20220378707A1 (en) | 2019-11-14 | 2022-12-01 | Pfizer Inc. | 1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
US4177256A (en) * | 1973-04-25 | 1979-12-04 | Alza Corporation | Osmotic bursting drug delivery device |
US4093708A (en) * | 1974-12-23 | 1978-06-06 | Alza Corporation | Osmotic releasing device having a plurality of release rate patterns |
US3952741A (en) * | 1975-01-09 | 1976-04-27 | Bend Research Inc. | Controlled release delivery system by an osmotic bursting mechanism |
US4016880A (en) * | 1976-03-04 | 1977-04-12 | Alza Corporation | Osmotically driven active agent dispenser |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
US4539199A (en) * | 1981-01-14 | 1985-09-03 | Egyt Gyogyszervegyeszeti Gyar | Sustained release pharmaceutical compositions |
US4522625A (en) * | 1982-09-29 | 1985-06-11 | Alza Corporation | Drug dispenser comprising wall formed of semipermeable member and enteric member |
DE3243710A1 (de) * | 1982-11-25 | 1984-05-30 | Delma, elektro- und medizinische Apparatebau GmbH, 7200 Tuttlingen | Operationsleuchte |
US4851231A (en) * | 1982-12-13 | 1989-07-25 | Alza Corporation | System for delivering drug in selected environment of use |
US4773907A (en) * | 1982-12-20 | 1988-09-27 | Alza Corporation | Primary delivery system comprising secondary dosage form |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4587117A (en) * | 1983-06-06 | 1986-05-06 | Alza Corporation | Medical device for delivering drug to pH environments greater than 3.5 |
US4503030A (en) * | 1983-06-06 | 1985-03-05 | Alza Corporation | Device for delivering drug to certain pH environments |
US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
US4705515A (en) * | 1984-10-26 | 1987-11-10 | Alza Corporation | Dosage form for administering drug of the colon |
US4627851A (en) * | 1984-10-26 | 1986-12-09 | Alza Corporation | Colonic-therapeutic delivery system |
US4693895A (en) * | 1984-10-26 | 1987-09-15 | Alza Corporation | Colon delivery system |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
IL77186A0 (en) * | 1985-11-29 | 1986-04-29 | Touitou Elka | Pharmaceutical insulin composition |
SE460945B (sv) * | 1987-01-15 | 1989-12-11 | Lejus Medical Ab | En multipel-unit-dos komposition av furosemid |
US4830855A (en) * | 1987-11-13 | 1989-05-16 | Landec Labs, Inc. | Temperature-controlled active agent dispenser |
US4904474A (en) * | 1988-01-25 | 1990-02-27 | Alza Corporation | Delivery of drug to colon by oral disage form |
US5472710A (en) * | 1988-04-16 | 1995-12-05 | Schwarz Pharma Ag | Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture |
JP2792862B2 (ja) * | 1988-07-30 | 1998-09-03 | 寛治 高田 | 経口腸溶製剤 |
IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane |
EP0408496A3 (en) * | 1989-07-12 | 1992-07-01 | Ciba-Geigy Ag | Solid dosage form for pharmaceutical substances |
US5178866A (en) * | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
CA2100272A1 (en) * | 1991-01-03 | 1992-07-04 | Thomas Patrick Molloy | Method for production of solid pharmaceutical preparation |
US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
NZ242065A (en) * | 1991-03-26 | 1996-06-25 | Csl Ltd | Delayed release implant having a degradable or rupturable polymeric coating |
US5364634A (en) * | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
-
1993
- 1993-02-25 US US08/023,227 patent/US5358502A/en not_active Expired - Fee Related
- 1993-11-16 TW TW082109592A patent/TW283641B/zh active
- 1993-12-28 JP JP5338066A patent/JP2862222B2/ja not_active Expired - Fee Related
-
1994
- 1994-02-11 ES ES94301026T patent/ES2157953T3/es not_active Expired - Lifetime
- 1994-02-11 EP EP94301026A patent/EP0612520B1/en not_active Expired - Lifetime
- 1994-02-11 DK DK94301026T patent/DK0612520T3/da active
- 1994-02-11 PT PT94301026T patent/PT612520E/pt unknown
- 1994-02-11 DE DE69427664T patent/DE69427664T2/de not_active Expired - Fee Related
- 1994-02-11 AT AT94301026T patent/ATE202927T1/de not_active IP Right Cessation
- 1994-02-17 IL IL10869194A patent/IL108691A0/xx unknown
- 1994-02-23 MX MX9401396A patent/MX9401396A/es unknown
- 1994-02-23 CA CA002116288A patent/CA2116288C/en not_active Expired - Fee Related
- 1994-02-24 NO NO19940642A patent/NO312123B1/no unknown
- 1994-02-24 ZA ZA941262A patent/ZA941262B/xx unknown
- 1994-02-24 FI FI940866A patent/FI113941B/fi not_active IP Right Cessation
- 1994-02-24 CN CN94102101A patent/CN1098286A/zh active Pending
- 1994-02-24 NZ NZ250967A patent/NZ250967A/en unknown
- 1994-02-24 AU AU56400/94A patent/AU660386B2/en not_active Ceased
- 1994-10-19 US US08/325,730 patent/US5609590A/en not_active Expired - Fee Related
-
2001
- 2001-08-31 GR GR20010401357T patent/GR3036497T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL108691A0 (en) | 1994-05-30 |
CN1098286A (zh) | 1995-02-08 |
DE69427664D1 (de) | 2001-08-16 |
NZ250967A (en) | 1996-02-27 |
AU5640094A (en) | 1994-09-22 |
US5358502A (en) | 1994-10-25 |
FI113941B (fi) | 2004-07-15 |
ATE202927T1 (de) | 2001-07-15 |
TW283641B (fi) | 1996-08-21 |
DK0612520T3 (da) | 2001-09-17 |
ES2157953T3 (es) | 2001-09-01 |
AU660386B2 (en) | 1995-06-22 |
JP2862222B2 (ja) | 1999-03-03 |
FI940866A0 (fi) | 1994-02-24 |
EP0612520A3 (en) | 1995-11-15 |
CA2116288A1 (en) | 1994-08-26 |
JPH072645A (ja) | 1995-01-06 |
GR3036497T3 (en) | 2001-11-30 |
EP0612520B1 (en) | 2001-07-11 |
NO940642D0 (no) | 1994-02-24 |
US5609590A (en) | 1997-03-11 |
NO940642L (no) | 1994-08-26 |
ZA941262B (en) | 1995-08-24 |
NO312123B1 (no) | 2002-03-25 |
CA2116288C (en) | 1997-11-18 |
DE69427664T2 (de) | 2001-10-25 |
EP0612520A2 (en) | 1994-08-31 |
MX9401396A (es) | 1994-08-31 |
PT612520E (pt) | 2001-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI940866A (fi) | pH-herkällä laukaisimella varustetut, osmoottiset, hajoavat laitteet aineen vapauttamiseksi | |
DE69208104D1 (de) | Orale, osmotische vorrichtung | |
ES551505A0 (es) | Un sistema osmotico lipidico para dispersar agentes farmacologicamente activos. | |
BE899464A (fr) | Composition a liberation soutenue de propanolol. | |
LV12452A (lv) | Aktivas vielas vaginala ievadisanas sistema | |
IT1201136B (it) | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive | |
DE69425828D1 (de) | Osmotische vorrichtung mit dampfdurchlaessiger beschichtung | |
DE69322286D1 (de) | Verabreichungsvorrichtungen mit gestützten flüssigen membranen | |
IE851524L (en) | Osmotically active system for dispensing drugs | |
IE882898L (en) | Solubility modulated drug delivery device | |
ES2022984B3 (es) | Dispositivo para deshidratacion controlada por absorcion de agua. | |
DK595987D0 (da) | Osmotisk kontinuerligt dispenserende oralt afgivelsessystem indeholdende et moderat vandoploeseligt metoprololsalt | |
AR000076A1 (es) | Formulación de polvo humectable, dispersion acuosade dicha formulación de polvo humectable, proce so para preparar dicha formulacion, metodo para administar dicha dispersion acuosa y metodo para el tratamiento de post-emergencia de malezas objetivoen un cultivo con dicha dispersion acuosa. | |
BR9106314A (pt) | Sistema portatil de purificacao de agua | |
JPS5519232A (en) | Preparation of slow-releasing capsule containing physiologically active substance | |
ITBO970017U1 (it) | Il trotatore componibile e variabile x 12 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |